DE69531891D1 - Virus, welches die Pankreas-Krankheit bei Fischen verursacht - Google Patents
Virus, welches die Pankreas-Krankheit bei Fischen verursachtInfo
- Publication number
- DE69531891D1 DE69531891D1 DE69531891T DE69531891T DE69531891D1 DE 69531891 D1 DE69531891 D1 DE 69531891D1 DE 69531891 T DE69531891 T DE 69531891T DE 69531891 T DE69531891 T DE 69531891T DE 69531891 D1 DE69531891 D1 DE 69531891D1
- Authority
- DE
- Germany
- Prior art keywords
- virus
- fish
- pancreatic disease
- causes pancreatic
- causes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000700605 Viruses Species 0.000 title abstract 5
- 241000251468 Actinopterygii Species 0.000 title abstract 2
- 208000016222 Pancreatic disease Diseases 0.000 title abstract 2
- 241000277263 Salmo Species 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 231100000676 disease causative agent Toxicity 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 235000019688 fish Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9420956A GB9420956D0 (en) | 1994-10-18 | 1994-10-18 | Virus |
GBGB9508704.5A GB9508704D0 (en) | 1995-04-28 | 1995-04-28 | Virus |
GBGB9509425.6A GB9509425D0 (en) | 1995-05-10 | 1995-05-10 | "Virus" |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69531891D1 true DE69531891D1 (de) | 2003-11-13 |
Family
ID=27267435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69531891T Expired - Lifetime DE69531891D1 (de) | 1994-10-18 | 1995-10-13 | Virus, welches die Pankreas-Krankheit bei Fischen verursacht |
Country Status (9)
Country | Link |
---|---|
US (2) | US5939073A (de) |
EP (1) | EP0712926B1 (de) |
JP (1) | JP3676449B2 (de) |
AT (1) | ATE251667T1 (de) |
CA (1) | CA2160764C (de) |
DE (1) | DE69531891D1 (de) |
DK (1) | DK0712926T3 (de) |
NO (2) | NO317547B1 (de) |
PT (1) | PT712926E (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69432199T2 (de) * | 1993-05-24 | 2004-01-08 | Sun Microsystems, Inc., Mountain View | Graphische Benutzerschnittstelle mit Verfahren zur Schnittstellebildung mit fernsteuernden Einrichtungen |
JP4323720B2 (ja) * | 1998-05-08 | 2009-09-02 | インターベツト・インターナシヨナル・ベー・ベー | 魚膵臓病ウイルス構造タンパク質およびその使用 |
CA2393895A1 (en) * | 2001-07-17 | 2003-01-17 | University Of Prince Edward Island | Serological test for isav in fish |
US6936256B2 (en) * | 2001-08-10 | 2005-08-30 | University Of Maryland Biotechnology Institute | Sub-unit vaccine for infectious pancreatic necrosis virus |
CA2541464C (en) | 2003-10-07 | 2016-02-09 | Michel Thiry | Piscirickettsia salmonis antigens and use thereof |
DK179025B1 (da) | 2005-09-16 | 2017-08-28 | Intervet Int Bv | Fiskevaccine |
JP2010514412A (ja) | 2006-12-22 | 2010-05-06 | ソリューシオネス バイオテクノロジカス イノヴァシオン リミターダ | Dna魚ワクチン |
AU2008337440B2 (en) | 2007-12-19 | 2013-05-02 | Intervet International B.V. | Vaccine antigens from Piscirickettsia salmonis |
NO346489B1 (no) * | 2008-02-08 | 2022-09-05 | Pharmaq As | Anvendelse av inaktivert SAV i fremstilling av en vaksine. |
NO333242B1 (no) * | 2008-02-08 | 2013-04-15 | Pharmaq As | Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus |
US9139618B2 (en) | 2010-12-29 | 2015-09-22 | Intervet Inc. | Salmonid alphavirus protein E2 |
EP2688587B2 (de) | 2011-03-25 | 2023-08-16 | Intervet International B.V. | Impfstoff gegen das lachs-alphavirus |
EP3037823A1 (de) | 2014-12-22 | 2016-06-29 | BioMar Group A/S | Verfahren zur Bestimmung pathologischer Gewebeschäden und Diagnose infektiöser Krankheiten bei Fischen |
KR102163242B1 (ko) * | 2018-06-05 | 2020-10-08 | 전남대학교산학협력단 | 무지개송어의 면역글로불린 m에 특이적인 단클론항체 및 이의 용도 |
NO344938B1 (en) | 2018-12-13 | 2020-07-20 | Patogen As | Pancreas Disease Virus Markers |
CN113122510A (zh) * | 2021-04-12 | 2021-07-16 | 中国水产科学研究院黑龙江水产研究所 | 一种传染性造血器官坏死病疫苗及其病毒在胖头鱥肌肉细胞上扩增的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5165925A (en) * | 1989-05-02 | 1992-11-24 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Vaccine for immunizing fish against infectious pancreatic necrosis virus |
-
1995
- 1995-10-13 DE DE69531891T patent/DE69531891D1/de not_active Expired - Lifetime
- 1995-10-13 EP EP95202771A patent/EP0712926B1/de not_active Expired - Lifetime
- 1995-10-13 PT PT95202771T patent/PT712926E/pt unknown
- 1995-10-13 DK DK95202771T patent/DK0712926T3/da active
- 1995-10-13 AT AT95202771T patent/ATE251667T1/de active
- 1995-10-17 NO NO19954135A patent/NO317547B1/no not_active IP Right Cessation
- 1995-10-17 CA CA002160764A patent/CA2160764C/en not_active Expired - Lifetime
- 1995-10-18 JP JP27017295A patent/JP3676449B2/ja not_active Expired - Lifetime
- 1995-10-18 US US08/544,681 patent/US5939073A/en not_active Expired - Lifetime
-
1997
- 1997-05-08 US US08/854,057 patent/US5914260A/en not_active Expired - Lifetime
-
2011
- 2011-10-28 NO NO2011024C patent/NO2011024I2/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0712926T3 (da) | 2004-02-09 |
JPH08228770A (ja) | 1996-09-10 |
JP3676449B2 (ja) | 2005-07-27 |
US5914260A (en) | 1999-06-22 |
NO317547B1 (no) | 2004-11-15 |
US5939073A (en) | 1999-08-17 |
CA2160764C (en) | 2002-09-03 |
EP0712926B1 (de) | 2003-10-08 |
NO2011024I2 (no) | 2015-09-07 |
NO2011024I1 (no) | 2011-11-14 |
NO954135D0 (no) | 1995-10-17 |
ATE251667T1 (de) | 2003-10-15 |
EP0712926A3 (de) | 1996-07-03 |
NO954135L (no) | 1996-04-19 |
PT712926E (pt) | 2004-02-27 |
CA2160764A1 (en) | 1996-04-19 |
EP0712926A2 (de) | 1996-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69531891D1 (de) | Virus, welches die Pankreas-Krankheit bei Fischen verursacht | |
WO1996010419A3 (en) | Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule | |
DE69536039D1 (de) | Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert | |
ATE233101T1 (de) | Polynukleotide vakzine gegen den papilloma virus | |
ES2065303T5 (es) | Procedimiento de diagnosis y vacuna especifica. | |
DE69637914D1 (de) | Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus | |
DK1165791T3 (da) | Humant cytokin som zalpha-receptor-ligand og anvendelse deraf | |
CA2189831A1 (en) | Dna-based vaccination of fish by immersion | |
DE69534992D1 (de) | Mutierendes enterotoxin als nichttoxisches orales adjuvans | |
BR9712971A (pt) | Método para produção de uma vacina para proteção de um hospedeiro contra doença causada com uma cadeia de chlamydia e composição imunológica | |
DE69939747D1 (de) | Verfahren von dna-impfung | |
AU2003244855A1 (en) | Method to enhance an immune response of nucleic acid vaccination | |
ZA923321B (en) | Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus | |
PT868522E (pt) | Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao | |
WO1999058639A3 (en) | Structural proteins of fish pancreatic disease virus and uses thereof | |
ATE78403T1 (de) | Impfstoff gegen mastitis. | |
PL307170A1 (en) | Vaccine against multicellular parasites | |
JPS5543040A (en) | Immunity raising agent | |
EP0839913A3 (de) | Auf DNA beruhende Impfung von Fishen durch Wässerung | |
ATE499383T1 (de) | Eine methode zur herstellung von menschlichem natürlichem interferon-alpha | |
DE69015602D1 (de) | Oxadiazolinon-Derivat, seine Herstellung und seine Verwendung. | |
WO1996002272A3 (en) | Treatment of autoimmune diseases | |
NL300026I1 (nl) | Varkenscholeravirusvaccin en diagnosticum. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |